Alerts will be sent to your verified email
Verify EmailSANOFI
Sanofi India
|
Procter&Gamble Healt
|
Natco Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Domestic Sales Growth - YoY
|
1.7 % | 20.1 % | 31.2 % |
Unclassified
|
|||
R&D as a % of Total Sales
|
0.0 | n/a | 7.6 % |
Financials
|
|||
5 yr Average ROE
|
52.02 % | 36.03 % | 13.06 % |
5yr average Equity Multiplier
|
4.62 | 2.53 | 1.18 |
5yr Average Asset Turnover Ratio
|
0.47 | 0.89 | 0.46 |
5yr Avg Net Profit Margin
|
24.38 % | 19.19 % | 23.09 % |
Price to Book
|
13.99 | 20.32 | 2.08 |
P/E
|
29.14 | 36.3 | 9.31 |
5yr Avg Cash Conversion Cycle
|
4.83 Days | -155.74 Days | 10.54 Days |
Inventory Days
|
66.8 Days | 36.01 Days | 99.95 Days |
Days Receivable
|
31.98 Days | 40.92 Days | 86.16 Days |
Days Payable
|
63.37 Days | 215.28 Days | 154.15 Days |
5yr Average Interest Coverage Ratio
|
906.11 | 500.05 | 46.61 |
5yr Avg ROCE
|
27.19 % | 34.48 % | 16.05 % |
5yr Avg Operating Profit Margin
|
24.71 % | 27.53 % | 30.17 % |
5 yr average Debt to Equity
|
0.0 | 0.0 | 0.06 |
5yr CAGR Net Profit
|
31.63 % | 4.02 % | 24.68 % |
5yr Average Return on Assets
|
11.5 % | 17.51 % | 11.07 % |
Shareholdings
|
|||
Promoter Holding
|
60.4 % | 51.82 % | 49.56 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.76 % |
Change in Mutual Fund Holding (3 Yrs)
|
1.2 % | 4.04 % | -4.64 % |
Sanofi India
|
Procter&Gamble Healt
|
Natco Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
Therapeutic Area Wise Break-Up - Domestic
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|